Supernus Pharmaceuticals Inc banner

Intrinsic Value

The intrinsic value of Supernus Pharmaceuticals Inc (SUPN) under the Base Case is USD per share. Compared with the current market price of 28.845 USD, the stock appears .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

SUPN Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when SUPN is below its intrinsic value
Today Hidden ·
SUPN Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to SUPN

Fundamental Analysis

What Supernus Pharmaceuticals Does

Pharmaceuticals Health Care

Supernus Pharmaceuticals is a specialty drug company that makes prescription medicines for central nervous system disorders, especially attention deficit hyperactivity disorder, epilepsy, migraine, and movement disorders. Its main products are branded medicines sold through pharmacies to patients with prescriptions from doctors. The company earns money when wholesalers and pharmacies buy those drugs and move them into the prescription chain.

Headquarters
United States of America US
Employees
778
IPO date
Dec 28, 2010
Read the full company overview
View Company Overview

Supernus Pharmaceuticals has no economic moat

No Moat Narrow Wide

Supernus Pharmaceuticals Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

Supernus Pharmaceuticals insiders are selling within their usual range

Insider trading · Last trade on Mar 18, 2026

Sold $6.8m 7 insiders
Bought $0 Nobody bought
Trades by date
Open insider trading

Continue SUPN Research

Decided on Supernus Pharmaceuticals? Get an email when SUPN reaches the price you’d buy at. Free with an account.

Other Supernus Pharmaceuticals listings

What is the Intrinsic Value of one SUPN stock?

The intrinsic value for Supernus Pharmaceuticals Inc (SUPN) under the Base Case is USD.

Is SUPN stock undervalued or overvalued?

Compared with the current market price of 28.845 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top